Global Intravenous (IV) Iron and Oral Iron Market 2017 Share, Trend, Segmentation and Forecast to 2022

WiseGuyReports.Com Publish a New Market Research Report On – “Global Intravenous (IV) Iron and Oral Iron Market 2017 Share,Trend,Segmentation and Forecast to 2022”.

Pune, India - January 30, 2017 /MarketersMedia/ —

Global intravenous (IV) iron and oral iron market is expected to cross US$ 3 billion by 2021, growing at a CAGR of 5%.

Iron drugs are the supplements containing iron prescribed by a doctor to treat anemia or other iron deficiencies. Oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body and intravenous (IV) iron therapy comes into the picture.

Global Intravenous (IV) Iron and Oral Iron market research report covers the present scenario and the growth prospects of the iron drugs market for the period 2016-2021. The report provides in-depth market analysis of market size and growth of Global Intravenous (IV) Iron and Oral Iron market.

Download Sample Report @ https://www.wiseguyreports.com/sample-request/912467-global-intravenous-iv-iron-forecast-till-2021

For more information or any query mail at [email protected]

Scope of the Report:

This market research report categories the Global Intravenous (IV) Iron and Oral Iron market based on mode of delivery, therapeutic area and geography. This market research includes a detailed market segmentation of the worldwide Intravenous (IV) iron and oral market by

By Mode of Delivery
• Oral Iron
• Ferrous Sulfate
• Carbonyl Iron
• Intravenous (IV) Iron
• Iron Dextran Complex
• Iron Sucrose
• Ferric Carboxymaltose

By Therapeutic Area
• Nephrology
• Gynecology and Obstetrics
• Gastroenterology
• Oncology
• Chronic Heart Failures
• Patient Blood Management

By Geography
• Americas
• APAC
• EMEA

By Country
• Africa
• Brazil
• Canada
• China
• France
• Germany
• India
• Italy
• Japan
• Mexico
• Netherland
• New Zealand
• Spain
• Switzerland
• UK
• US

Global Intravenous (IV) Iron and Oral Iron Market – Market Size and Dynamics
Analysts at Beige Market Intelligence expects the global intravenous (IV) iron and oral iron market to cross US$ 3 billion by 2021, growing at an impressive CAGR close to 5%. Iron drugs are widely used in various therapeutic areas like nephrology, gynaecology, oncology, gastroenterology, surgeries, and chronic heart failures. This catalyses the growth of global intravenous (IV) iron and oral iron market. Furthermore, factors such as correction of IDA in pregnancy, growing diabetic population worldwide, growing incidence of Chronic Kidney Disease (CKD) that increases the need of dialysis, prevalence of iron deficiency are the major factors attributing to the growth of the market.

The global intravenous (IV) iron and oral iron market is majorly categorised into two categories as per there mode of delivery such as oral and intravenous (IV). The oral delivery of iron in form of tablets, capsules, syrups is the most economic medical treatment for iron deficiency anaemia. Ferrous sulfate is the most common and cheapest form of oral therapy for treating patients with iron deficiency anemia. Though oral iron drugs market size is expected to increase to a notable figure over next five years, it can lose significant amount of its market share to intravenous (IV) iron therapies in near future.

Intravenously iron is delivered to patients who are either unable to absorb oral iron or who has increasing anemia despite adequate doses of oral iron. Growing incidence of Chronic Kidney Disease (CKD), iron deficiency diseases related to gynecology, nephrology, gastroenterology, and oncology is driving growth of the intravenous iron therapy. The high growth rate of IV iron market can be attributed to the paradigm shift of healthcare providers/patients to IV iron therapies from oral iron therapies.

The research report provides a detailed analysis and growth forecast of each therapeutic area. Nephrology is the largest application area of the intravenous (IV) iron and oral iron drugs followed by Gynecology and Gastroenterology.

Global Intravenous (IV) Iron and Oral Iron – Trends, Drivers, and Challenges
The market research report on intravenous (IV) iron and oral iron market provides a comprehensive study about the factors affecting the market growth and upcoming challenges. The research report describes the growth driving factors of the global intravenous (IV) iron and oral iron market for the next five years. Increasing number of dialysis patients and growing diabetic population worldwide are among the major drivers described in the intravenous (IV) iron and oral iron market research report.

Paradigm shift from oral iron drugs to intravenous (IV) iron drugs is a major trend in the market. There are gastrointestinal side effects associated with oral iron drugs like nausea, constipation, anorexia, heartburn, vomiting, and diarrhea and are intolerant even by healthy patients. Thus the side effects of oral iron drugs has attracted the patients towards intravenous (IV) iron. Also with the increasing awareness of IDA during pregnancy and shift towards healthier lifestyle; correction of IDA in pregnant women is the current trend driving the market for oral and IV iron.

..............

The report also provides the Porter’s five forces analysis along with a description of each of the forces and its impact on the market.

Complete Report Details @ https://www.wiseguyreports.com/reports/912467-global-intravenous-iv-iron-forecast-till-2021

Global Intravenous (IV) Iron and Oral Iron – Geographical Analysis

The report includes the market analysis of global intravenous (IV) iron and oral iron market in different regions such as the Americas, APAC, and EMEA. The report outlines the major market share holder in the global intravenous (IV) iron and oral iron market and the market size analysis of all the regions. The intravenous (IV) iron and oral iron market report also provides the market size and forecast of the key countries. The America region is expected to be the largest market for intravenous (IV) iron and oral iron drugs followed by EMEA. US, Canada, and Brazil are the key countries in this region contributing a major chunk of revenue.

………..CONTINUED

For more information or any query mail at [email protected]

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=912467

Contact Info:
Name: Norah Trent
Email: [email protected]
Organization: WiseGuy Research Consultants Pvt Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/global-intravenous-iv-iron-and-oral-iron-market-2017-share-trend-segmentation-and-forecast-to-2022/165367

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 165367